The Controller of Iridex Corp (NASDAQ: IRIX) is Selling SharesBy Carrie Williams
In addition to Dizon Romeo, one other IRIX executive reported Sell trades in the last month.
Based on Iridex Corp’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $12.53 million and GAAP net loss of $10.82 million. In comparison, last year the company earned revenue of $12.11 million and had a net profit of $438K. The company has a one year high of $16.64 and a one year low of $9.61. Currently, Iridex Corp has an average volume of 30.44K.
The insider sentiment on Iridex Corp has been positive according to 18 insider trades in the past three months. This sentiment is higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IRIDEX Corp. engages in the development, manufacture, and market of therapeutic based laser consoles, delivery devices, and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. It sells lasers, laser delivery and glaucoma devices; retina surgical instruments; veterinary, and ear, nose, and throat products. It operates through the following geographical segments: United State, Europe, Rest of Americas, and Asia/Pacific Rim. The company was founded by Eduardo Arias, Theodore A. Boutacoff, and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.